EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Cognitive behavioral phenotyping of DSCAM heterozygosity as a model for autism spectrum disorder

Ryan C Neff iD, Katherine A Stangis, Ujjawal Beniwal, Ty Hergenreder, Bing Ye, Geoffrey G Murphy iD

Genes, Brain and Behavior · 2024

DOI: 10.1111/gbb.70002 ↗

At a glance

Journal article in Genes, Brain and Behavior, 2024. Written by Ryan C Neff and 5 co-authors. Institution: Michigan Neuroscience Institute, University of Michigan Medical School, Ann Arbor, Michigan, USA. Major MEDLINE topics: Autism Spectrum Disorder, Cell Adhesion Molecules, Heterozygote. Cited 9 times so far (Crossref); 68 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIH HHS, NINDS NIH HHS, NIBIB NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

It is estimated that 1 in 36 children are affected by autism spectrum disorder (ASD) in the United States, which is nearly a twofold increase from a decade ago. Recent genetic studies have identified de novo loss‐of‐function (dnLoF) mutations in the Down Syndrome Cell Adhesion Molecule (DSCAM) as a strong risk factor for ASD. Previous research has shown that DSCAM ablation confers social interaction deficits and perseverative behaviors in mouse models. However, it remains unknown to what extent DSCAM underexpression captures the full range of behaviors, specifically cognitive phenotypes, presented in ASD. Here, we conducted a comprehensive cognitive behavioral phenotyping which revealed that loss of one copy of DSCAM , as in the DSCAM 2J +/−, that is, DSCAM heterozygous mice, displayed hyperactivity, increased anxiety‐like behavior, and motor coordination deficits. Additionally, hippocampal‐dependent learning and memory was affected, including impairments in working memory, long‐term memory, and contextual fear learning. Interestingly, implicit learning processes remained intact. Therefore, DSCAM LoF produces autistic‐like behaviors that are similar to those observed in human cases of ASD. These findings further support a role for DSCAM dnLoF mutations in ASD and suggest DSCAM 2J +/− as a suitable model for ASD research.

Subjects

MeSH terms (MEDLINE)

Autism Spectrum DisorderCell Adhesion MoleculesHeterozygoteAnimalsMiceMalePhenotypeDisease Models, AnimalMice, Inbred C57BLCognitionBehavior, AnimalFemaleAnxietyFear

Author keywords

DSCAMautism spectrum disorderbehaviorfear learninglearning and memoryspatial learning

Substances

Cell Adhesion MoleculesDscam protein, mouse

Authors and institutions

  • Michigan Neuroscience Institute, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.
  • Life Sciences Institute, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan, USA.

ORCID profiles: Ryan C Neff, Geoffrey G Murphy

Funding

  • NIH HHS
  • NINDS NIH HHS
  • NIBIB NIH HHS
  • NIA NIH HHS
  • Brain Research Foundation
  • National Institutes of Health

Cite

APA

Neff, R. C., Stangis, K. A., Beniwal, U., Hergenreder, T., Ye, B., & Murphy, G. G. (2024). Cognitive behavioral phenotyping of DSCAM heterozygosity as a model for autism spectrum disorder. Genes, Brain and Behavior. https://doi.org/10.1111/gbb.70002

Vancouver

Neff RC, Stangis KA, Beniwal U, Hergenreder T, Ye B, Murphy GG. Cognitive behavioral phenotyping of DSCAM heterozygosity as a model for autism spectrum disorder. Genes, Brain and Behavior. 2024. doi:10.1111/gbb.70002

BibTeX
@article{Neff2024,
  author = {Neff, Ryan C and Stangis, Katherine A and Beniwal, Ujjawal and Hergenreder, Ty and Ye, Bing and Murphy, Geoffrey G},
  title = {Cognitive behavioral phenotyping of DSCAM heterozygosity as a model for autism spectrum disorder},
  journal = {Genes, Brain and Behavior},
  year = {2024},
  doi = {10.1111/gbb.70002}
}
Start for free →